References
1 Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol 2018;24:3980-3999.
2 Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 2019;156:477-491.
3 Kudo M, Fin RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron Ari, Park JW, Han G, Jassem J, Blanc J-F, Vogel A, Komov D, Evans TR-J, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng A-L. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 2018;391:1163-1173.
4 Prokurat A, Kluge P, Kosciesza A, Perek D, Kappeler A, Zimmermann A. Transitional liver cell tumor (TLCT) in older children and adolescents: A novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 2002;39:510-518.
5 H N Ozcan, B Oguz, T Salim, B Talim, M Halilogu. A rare malignant hepatic tumor of childhood: Transisional liver cell tumor revisited. JBR-BTR 2015;98:79-81.
6 F Sasaki, T Matsunaga, M Iwafuchi, Y Hayashi, H Ohkawa, M Ohira, T Okamatsu, T Sugito, Y Tsuchida, A Toyosaka, N Nagahara, H Nishihira, Y Hata, J Uvhino, K Misugi, N Ohnuma, (Japanese Study Group for Pediatric Liver Tumor). Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 2002;37:851-856.
7 G Perilongo, E shafford, R Maibach, D Aronson, L Brugieres, P Brock, M Childs, P Czauderna, G MacKinlay, J Pritchard, R Rondelli, M Scopinaro, C staalman, J Plaschkes, International Society of Pediatric Oncology-SIOPEL2. Risk-adapted treatment for childhood hepatoblastoma final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2. Eur J Cancer 2004;40:411-421.
8 P F Ehrich, M L Greenberg, R M Filler. Improved long-term survival with preoperative chemotherapy for hepatoblastoma. J Pediatr Surg 1997;32:999-1002.
9 Marcio H Malogolowkin, Howard M Katzenstein, Rebecka L Meyers, Mark Krailo, Jon M Rowland, Joel Haas, Milton J Finegold. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: A report from the Children’s Oncology Group. J Clin Oncol 2011;29:3301-3306.
10 Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Browman LC. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group Intergroup Study. J Clin Oncol 2002;20:2789-2797.
11 Haines K, Sarabia SF, Alvarez KR, Tomlinson G, Vasudevan SA, Heczey AA, Roy A, Finegold MJ, Parsons DW, Plon SE, Lopez-Terrada D. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. 2019. Pediatr Blood Cancer 2019;66:doi: 10.1002/pbc.27745.
12 Yamaoka H, Ohtsu K, Sueda T, Yokoyama T, Hiyama E. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Oncol Rep 2006;15:551-556.
13 Jayasinghe RG, Cao S, Gao Q, Wendl MC, Vo NS, Reynolds SM, Zhao Y, Climente-González H, Chai S, Wang F, Varghese R, Huang M, Liang WW, Wyczalkowski MA, Sengupta S, Li Z, Payne SH, Fenyȍ D, Miner JH, Walter MJ, Cancer Genome Atlas Reseach Network; Vincent B, Eyras E, Chen K, Shmulevich I, Chen F, Ding L. Systematic analysis of splice-site-creating mutations in cancer. 2018 Cell Rep 2018;23:270-281.e3.